Advanced Viral Research Corp. Names Abbott Veteran Angelo S. Botter To Its Board Of Directors

YONKERS, N.Y.--(BUSINESS WIRE)--May 31, 2006--Advanced Viral Research Corp. (OTC Bulletin Board: ADVR - News) a bio-pharmaceutical company, announced today that its Board of Directors has voted and appointed Angelo S. Botter to the Board of Directors. Mr. Botter brings a wealth of pharmaceutical experience to Advanced Viral. Mr. Botter has held senior executive positions at several large multi-national pharmaceutical corporations during his impressive career. Most notably, Mr. Botter held an executive position for twenty-one years at Abbott Labs. Mr. Botter and his team helped facilitate the launch of all new Abbott products in HIV, anti-infective, gastroenterology, cancer therapy, immunology and cardiovascular fields. He was integral in concluding several in-marketing and co-licensing deals with other pharmaceutical companies.
MORE ON THIS TOPIC